-+ 0.00%
-+ 0.00%
-+ 0.00%

Gilead Sciences Chairman and CEO Daniel Patrick O'Day Reports Sale of $19.69 Million in Common Shares

PUBT·11/06/2026 22:17:30
Listen to the news
Gilead Sciences Chairman and CEO Daniel Patrick O'Day Reports Sale of $19.69 Million in Common Shares
  • Gilead Sciences Chairman and CEO Daniel Patrick O'Day sold 112,429 common shares on Nov. 4-5, 2026.
  • The Nov. 4 sale covered 102,619 shares at $175.1627 per share.
  • On Nov. 5, he sold 9,810 shares at $175.17 per share.
  • He exercised non-qualified stock options to acquire the same number of shares at $72.34 per share.
  • His remaining direct holdings totaled 551,683 common shares and 128,310 non-qualified stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001638643-26-000040), on November 06, 2026, and is solely responsible for the information contained therein.